303 related articles for article (PubMed ID: 21440102)
1. [Potential of liposomes for the intravitreal injection of therapeutic molecules].
Bochot A; Lajavardi L; Camelo S; Bourges JL; Behar-Cohen F; de Kozak Y; Fattal E
Ann Pharm Fr; 2011 Mar; 69(2):100-7. PubMed ID: 21440102
[TBL] [Abstract][Full Text] [Related]
2. Liposomes for intravitreal drug delivery: a state of the art.
Bochot A; Fattal E
J Control Release; 2012 Jul; 161(2):628-34. PubMed ID: 22289436
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery to the posterior segment of the eye.
Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
[TBL] [Abstract][Full Text] [Related]
4. Medical devices for the treatment of eye diseases.
Yasukawa T; Ogura Y
Handb Exp Pharmacol; 2010; (197):469-89. PubMed ID: 20217540
[TBL] [Abstract][Full Text] [Related]
5. Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration.
Claro C; Ruiz R; Cordero E; Pastor MT; López-Cortés LF; Jiménez-Castellanos M; Lucero M
Exp Eye Res; 2009 Mar; 88(3):528-34. PubMed ID: 19084004
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Myles ME; Neumann DM; Hill JM
Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.
Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Wiley CA; Freeman WR
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1487-95. PubMed ID: 10359331
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
Short BG
Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
Bochot A; Fattal E; Boutet V; Deverre JR; Jeanny JC; Chacun H; Couvreur P
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):253-9. PubMed ID: 11773039
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery systems for vitreoretinal diseases.
Yasukawa T; Ogura Y; Tabata Y; Kimura H; Wiedemann P; Honda Y
Prog Retin Eye Res; 2004 May; 23(3):253-81. PubMed ID: 15177203
[TBL] [Abstract][Full Text] [Related]
11. Nanotherapy for posterior eye diseases.
Kaur IP; Kakkar S
J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
[TBL] [Abstract][Full Text] [Related]
12. [The use of liposomes as intravitreal drug delivery system].
Bejjani RA; Jeanny JC; Bochot A; Behar-Cohen F
J Fr Ophtalmol; 2003 Nov; 26(9):981-5. PubMed ID: 14631286
[TBL] [Abstract][Full Text] [Related]
13. Novel drug delivery systems for retinal diseases. A review.
Lee SS; Robinson MR
Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
Jonas JB; Kreissig I; Degenring R
Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
[TBL] [Abstract][Full Text] [Related]
16. Periocular routes for retinal drug delivery.
Raghava S; Hammond M; Kompella UB
Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal drug therapy.
Peyman GA; Schulman JA
Jpn J Ophthalmol; 1989; 33(4):392-404. PubMed ID: 2696799
[TBL] [Abstract][Full Text] [Related]
18. Clearance and localization of intravitreal liposomes in the aphakic vitrectomized eye.
Stern WH; Heath TD; Lewis GP; Guerin CJ; Erickson PA; Lopez NG; Hong KL
Invest Ophthalmol Vis Sci; 1987 May; 28(5):907-11. PubMed ID: 3032840
[TBL] [Abstract][Full Text] [Related]
19. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes.
Zhang R; He R; Qian J; Guo J; Xue K; Yuan YF
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3575-82. PubMed ID: 20164461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
